Skip to main content
. Author manuscript; available in PMC: 2019 Jun 18.
Published in final edited form as: J Clin Pathol. 2018 Nov 22;72(3):258–262. doi: 10.1136/jclinpath-2018-205570

Figure 2. MED12 exon 2 mutations identified by Sanger sequencing in fibroadenomas and benign phyllodes tumor in young female patients.

Figure 2.

Representative photomicrographs and sequence electropherograms of different missense SNVs and in-frame deletions targeting exon 2 of MED12 in fibroadenomas and benign phyllodes tumors identified in young female patients by Sanger sequencing. The aminoacid change is indicated for each case. Arrows point to the altered base. Scale bars, 100 μm.